---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-029686"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2022-10-27T23:59:59+00:00"
generated_at: "2026-06-23T00:06:36.884625+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GBS Inc. changes name to Intelligent Bio Solutions; appoints Harry Simeonidis as CEO

## Summary
- Company name changed from GBS Inc. to Intelligent Bio Solutions Inc.; effective Oct 26, 2022.
- Nasdaq ticker changes from GBS to INBS effective Oct 27, 2022.
- Harry Simeonidis appointed President and CEO, succeeding Steven Boyages who remains Chairman.
- David Jenkins and Jason Isenberg appointed to Board of Directors.

## SEC filing metadata
- accession: 0001493152-22-029686
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2022-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-029686
- JSON: https://secwatch.observer/filing/0001493152-22-029686.json
- Plain text: https://secwatch.observer/filing/0001493152-22-029686.txt

## Key facts
- Executive change
  Steven Boyages changed role as Interim Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..
  - Action: stepping down
  - Role: Interim Chief Executive Officer
  source text: Dr. Steven Boyages, who is stepping down as the Company’s Interim Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm
- Executive change
  Harry Simeonidis was elected as President and Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..
  - Action: elected
  - Role: President and Chief Executive Officer
  source text: elected Harry Simeonidis, who currently serves as the Company’s President Asia Pacific, Sales and Marketing, as the Company’s President and Chief Executive Officer, effective as of October 26, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.